Abstract
Groups of younger and aged mice were fed either minimal basal diet or the same diet containing 40 ppm melatonin. After 9.3 weeks half of each of these 4 groups of animals received either an intraperitoneal injection of lipopolysaccharide (LPS) or of saline. Three hours after this treatment, all animals were killed and mRNA from brains extracted. Quantitative PCR was performed on 13 selected mRNA species reflecting various aspects of the inflammatory pathway, the melatonin receptor, and a key glycolytic enzyme. An overall trend observed was that the effect of melatonin in modulating LPS-provoked immune responses differed markedly in old and young animals. Melatonin tended to enhance the reaction of younger animals to LPS but suppressed the inflammatory response of older mice. This difference with aging suggests that key immune processes are markedly altered by aging. It is likely that the ability of the immune system to mount a defense is impaired in older animals.
Keywords: Aging, brain, melatonin, gene expression
Current Aging Science
Title: Melatonin Causes Gene Expression in Aged Animals to Respond to Inflammatory Stimuli in a Manner Differing from that of Young Animals
Volume: 1 Issue: 3
Author(s): Edward H. Sharman, Kaizhi G. Sharman and Stephen C. Bondy
Affiliation:
Keywords: Aging, brain, melatonin, gene expression
Abstract: Groups of younger and aged mice were fed either minimal basal diet or the same diet containing 40 ppm melatonin. After 9.3 weeks half of each of these 4 groups of animals received either an intraperitoneal injection of lipopolysaccharide (LPS) or of saline. Three hours after this treatment, all animals were killed and mRNA from brains extracted. Quantitative PCR was performed on 13 selected mRNA species reflecting various aspects of the inflammatory pathway, the melatonin receptor, and a key glycolytic enzyme. An overall trend observed was that the effect of melatonin in modulating LPS-provoked immune responses differed markedly in old and young animals. Melatonin tended to enhance the reaction of younger animals to LPS but suppressed the inflammatory response of older mice. This difference with aging suggests that key immune processes are markedly altered by aging. It is likely that the ability of the immune system to mount a defense is impaired in older animals.
Export Options
About this article
Cite this article as:
Sharman H. Edward, Sharman G. Kaizhi and Bondy C. Stephen, Melatonin Causes Gene Expression in Aged Animals to Respond to Inflammatory Stimuli in a Manner Differing from that of Young Animals, Current Aging Science 2008; 1 (3) . https://dx.doi.org/10.2174/1874609810801030152
DOI https://dx.doi.org/10.2174/1874609810801030152 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chagas Heart Disease Pathogenesis: One Mechanism or Many?
Current Molecular Medicine Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
Current Medicinal Chemistry Polymorphism Gln27Glu of β2 Adrenergic Receptors in Patients with Ischaemic Cardiomyopathy
Current Vascular Pharmacology Sacubitril/Valsartan: A New Dawn has Begun! A Revisited Review
Current Cardiology Reviews Decreased Vascular Repair and Neovascularization with Ageing: Mechanisms and Clinical Relevance with an Emphasis on Hypoxia- Inducible Factor-1
Current Molecular Medicine Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Stage B: What is the Evidence for Treatment of Asymptomatic Left Ventricular Dysfunction?
Current Cardiology Reviews Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Current Neuropharmacology Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Obesity in Cardiomyopathy and Nephropathy
Current Pharmaceutical Design Post-traumatic Stress Disorder in Heart Failure Patients: A Test of the Cardiac Disease-induced PTSD Hypothesis
Current Psychiatry Research and Reviews Twin-to-Twin Transfusion Syndrome: From Placental Anastomoses to Long-Term Neurodevelopmental Outcome
Current Pediatric Reviews An Overview of Published Papers and Important Developments in the Past Three Years
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Sarcoidosis in Pregnancy and Postpartum Period
Current Respiratory Medicine Reviews Withdrawal Notice: Therapeutic Options for Treatment of COVID-19: A Review from Repurposed Drugs to New Drug Targets
Current Drug Targets How to Recognize Epicardial Origin of Ventricular Tachycardias?
Current Cardiology Reviews The Metabolic Approach in Patients with Heart Failure: Effects on Left Ventricle Remodeling
Current Pharmaceutical Design Neuroprotection by Resveratrol in Diabetic Neuropathy: Concepts & Mechanisms
Current Medicinal Chemistry Mitochondria-Targeted Drugs
Current Molecular Pharmacology Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice
Current Drug Safety